Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Kelun Biotech Plans Hong Kong IPO to Develop ADCs and Other Products

Structure Stages Expanded $161 Million IPO for Novel Small Molecules

Structure, a US-China Company, Files for $100 Million NASDAQ IPO

Boan Stages $20 Million Hong Kong IPO for Biosimilar/Novel mAb Drugs

Boan Biotech’s IPO Application Accepted by Hong Kong Exchange

ChinaBio Event
Singapore and Digital
April 26-27, 2023
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China